arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

COMPASS Pathways plc

CMPS
$13.55 ▲ +0.01 (+0.04%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
8 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
54
Health
Fair
Bullish
auto_awesome

Analytical Summary

COMPASS Pathways plc shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.3B
Dividend Yield
Revenue Growth
Op. Margin
ROIC 836.7%
FCF / Share $-1.68
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -0.60
info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-287.86M
↓ -85.6%
FCF / Share Free cash flow per share
$-1.68
↑ +4.8%
Long-Term Debt Long-term obligations
$31.63M
↑ +4.9%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Financial Health
59
Cash Quality
42

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 26 quarters